Management will host a conference call at 8:00 am ET to review the quarterly figures and field questions from stakeholders. Participants planning to join via teleconference must register in advance to receive a personalized dial-in number and PIN. Access to a live webcast is available through the company’s investor relations portal, with an archived replay scheduled to remain accessible for one year starting at 11:00 am ET on the day of the announcement.
Haemonetics operates across the apheresis and medical-surgical sectors, focusing on blood management and interventional technologies. Investors may reach out to Olga Guyette or David Trenk for further inquiries regarding the fiscal update.
Comments (0)
No comments yet. Be the first!